On the whole, these results support the hypothesis that the molecular mechanisms by which gender affects medulloblastoma may involve the ERβ signaling, and reinforce the growing body of evidence that an imbalanced ERβ expression might play a pivotal role in the development and progression of many tumor types [36]. The gene discussed is ESR2; the disease is neoplasm.